BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for SPARK THERAPEUTICS, INC. · Biopharmaceutical/gene therapy company

Filing 2nd Quarter - Termination

2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · $30,000.00 income · posted Jul 16, 2025

Lobbying activity 1

Health Issues

Issues related to the development of gene therapies for rare diseases

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.